subject area of
- 5-Fluorouracil with Folinic Acid is Not Effective Against Metastatic Adenocarcinoma of the Lung Academic Article
- A Methanol Intoxication Outbreak From Recreational Ingestion of Fracking Fluid Academic Article
- A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial Academic Article
- A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer Academic Article
- Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity Academic Article
- Cervical Ectopic Pregnancy Complicated by Escherichia Coli Septicemia: A Case Report Academic Article
- Comparison of leucovorin protection from variety of antifolates in human lymphoid cell lines Academic Article
- Comparison of thymidine and folinic acid protection from methotrexate toxicity in human lymphoid cell lines. Academic Article
- Differential calcium leucovorin protection of human lymphoid cell lines from methotrexate Academic Article
- High-Dose Methotrexate for Gestational Trophoblastic Disease Academic Article
- Medical Management of a Cervical Pregnancy: A Case Report Academic Article
- Methionine transfer RNAs from the extreme halophile, Halobacterium cutirubrum Academic Article
- Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial. Academic Article
- Overstated Conclusions of a Pooled Analysis of Bevacizumab in Colon Cancer Academic Article
- PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy Academic Article
- Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy Academic Article
- Randomized, Placebo-Controlled, Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Metastatic Colorectal Adenocarcinoma Academic Article
- STABILIZATION OF DIHYDROFOLATE REDUCTASE BY INHIBITORS IN VIVO AND IN VITRO Academic Article
- Treatment of central nervous system tumors with methotrexate. Academic Article
- Weekly Intravenous Methotrexate with Folinic Acid for Nonmetastatic Gestational Trophoblastic Neoplasia Academic Article